slotkoers
Shenzhen S.E.
00:00:00 07-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
29,89
CNY
|
-0,70%
|
|
+3,97%
|
+15,05%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
8.632
|
8.620
|
8.527
|
9.495
|
13.469
|
15.172
|
Bedrijfswaarde
1 |
7.356
|
7.375
|
6.889
|
7.446
|
10.057
|
11.597
|
K/w-verhouding
|
15,4
x
|
15,2
x
|
14,7
x
|
13,6
x
|
15,7
x
|
13,5
x
|
Dividendrendement
|
6,77%
|
6,78%
|
2,39%
|
4,25%
|
4,31%
|
5,77%
|
Marktkapitalisatie/omzet
|
1,93
x
|
1,97
x
|
2,46
x
|
2,13
x
|
2,64
x
|
2,66
x
|
Bedrijfswaarde/omzet
|
1,64
x
|
1,69
x
|
1,99
x
|
1,67
x
|
1,97
x
|
2,03
x
|
Bedrijfswaarde/EBITDA
|
9,45
x
|
8,7
x
|
8,52
x
|
7,97
x
|
7,84
x
|
8,55
x
|
Bedrijfswaarde/FCF
|
25,4
x
|
23,2
x
|
10,1
x
|
10,5
x
|
6,48
x
|
31
x
|
FCF Yield
|
3,94%
|
4,31%
|
9,88%
|
9,52%
|
15,4%
|
3,22%
|
Price to Book
|
2,64
x
|
2,67
x
|
2,66
x
|
2,61
x
|
3,22
x
|
3,19
x
|
Aantal aandelen (in duizenden)
|
584.000
|
584.000
|
581.265
|
576.870
|
581.050
|
584.000
|
Referentieprijs
2 |
14,78
|
14,76
|
14,67
|
16,46
|
23,18
|
25,98
|
Datum van publicatie
|
20-03-19
|
27-04-20
|
20-04-21
|
21-04-22
|
11-04-23
|
25-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
4.472
|
4.371
|
3.462
|
4.461
|
5.095
|
5.700
|
EBITDA
1 |
778,5
|
847,9
|
809
|
933,8
|
1.283
|
1.356
|
Bedrijfsresultaat (EBIT)
1 |
635,7
|
702,2
|
661,9
|
771,3
|
1.022
|
1.184
|
Operationele Marge
|
14,21%
|
16,06%
|
19,12%
|
17,29%
|
20,07%
|
20,76%
|
Resultaat voor belastingen (EBT)
1 |
720,4
|
778
|
766,8
|
894,5
|
1.081
|
1.355
|
Nettowinst (verlies)
1 |
563,3
|
565,4
|
584,5
|
704,7
|
867,2
|
1.119
|
Nettomarge
|
12,6%
|
12,93%
|
16,88%
|
15,8%
|
17,02%
|
19,63%
|
WPA
2 |
0,9600
|
0,9700
|
1,000
|
1,210
|
1,480
|
1,920
|
Free Cash Flow
1 |
289,7
|
317,9
|
681
|
708,5
|
1.552
|
373,9
|
FCF-marge
|
6,48%
|
7,27%
|
19,67%
|
15,88%
|
30,47%
|
6,56%
|
Kasstroomconversie (ebitda)
|
37,21%
|
37,49%
|
84,17%
|
75,88%
|
121,02%
|
27,57%
|
Kasstroomconversie (nettowinst)
|
51,42%
|
56,23%
|
116,51%
|
100,54%
|
179,02%
|
33,41%
|
Dividend per aandeel
2 |
1,000
|
1,000
|
0,3500
|
0,7000
|
1,000
|
1,500
|
Datum van publicatie
|
20-03-19
|
27-04-20
|
20-04-21
|
21-04-22
|
11-04-23
|
25-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.276
|
1.244
|
1.638
|
2.049
|
3.411
|
3.576
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
290
|
318
|
681
|
709
|
1.552
|
374
|
ROE (netto-inkomsten/eigen vermogen)
|
18,4%
|
18,5%
|
18,2%
|
20,8%
|
21,7%
|
24,7%
|
ROA (netto-inkomsten/totale activa)
|
8,34%
|
8,47%
|
7,94%
|
8,97%
|
10,1%
|
10,6%
|
Totale activa
1 |
6.755
|
6.679
|
7.362
|
7.857
|
8.595
|
10.526
|
Nettoactief per aandeel
2 |
5,600
|
5,540
|
5,510
|
6,310
|
7,200
|
8,160
|
Cashflow per aandeel
2 |
2,100
|
2,520
|
2,860
|
2,250
|
4,110
|
3,920
|
Capex
1 |
321
|
374
|
213
|
118
|
153
|
149
|
Capex/omzet
|
7,18%
|
8,56%
|
6,14%
|
2,65%
|
3%
|
2,62%
|
Datum van publicatie
|
20-03-19
|
27-04-20
|
20-04-21
|
21-04-22
|
11-04-23
|
25-04-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +15,05% | 2,41 mld. | | +19,64% | 43,3 mld. | | +21,25% | 22,22 mld. | | +18,92% | 15,43 mld. | | +20,14% | 14,48 mld. | | +53,19% | 12,72 mld. | | -0,05% | 6,79 mld. | | -11,11% | 6,71 mld. | | -8,87% | 5,73 mld. | | +14,68% | 5,5 mld. |
Generieke geneesmiddelen
|